Chimeron Bio Corp — Form D/A

Chimeron Bio Corp of PHILADELPHIA, PA, a company, filed a Form D amendment with the SEC on 2025-03-14. $12.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (18)

NameRoleLocation
Antonin de FougerollesDirectorPhiladelphia, PA
Kevin HeyeckDirectorPhiladelphia, PA
Afshin SafaviDirectorPhiladelphia, PA
Monica ColemanExecutive OfficerPhiladelphia, PA
Kevin HeyeckExecutive OfficerPhiladelphia, PA
Hemanshu PandyaDirectorNEW YORK, NY
Gorka FiusDirectorCambridge, MA
Thimmaiah ChendrimadaDirectorPhiladelphia, PA
Thimmaiah ChendrimadaExecutive OfficerPhiladelphia, PA
Thimmaiah ChendrimadaPromoterPhiladelphia, PA
Chiraag PatelDirectorPhiladelphia, PA
Jolly MazmudarDirectorPhiladelphia, PA
Jolly MazmudarExecutive OfficerPhiladelphia, PA
Jolly MazmudarPromoterPhiladelphia, PA
Monica Dilip ColemanExecutive OfficerPhiladelphia, PA
Afshin Dilip SafaviDirectorPhiladelphia, PA
Chiraag Dilip PatelDirectorPhiladelphia, PA
Hemanshu Dilip PandyaDirectorPhiladelphia, PA

Other filings by this issuer (4)

FiledFormOfferingSold
2025-03-03D$13.7M
2022-11-30D$10.0M$1.2M
2022-03-10D$3.0M$782K
2020-12-28D$5.0M$300K

More